Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $514B
1-Year Return 19.74%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Quarter Return
-0.28%
1 Year Return
+19.74%
3 Year Return
+61.35%
5 Year Return
+115.83%
10 Year Return
+214.11%
AUM
$357B
AUM Growth
+$195M
Cap. Flow
+$2.36B
Cap. Flow %
0.66%
Top 10 Hldgs %
19.84%
Holding
7,588
New
455
Increased
3,725
Reduced
2,395
Closed
362

Sector Composition

1 Financials 21.66%
2 Technology 14.22%
3 Communication Services 8.29%
4 Healthcare 8.27%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BEKE icon
5651
KE Holdings
BEKE
$23.7B
$41K ﹤0.01%
2,262
-7,541
-77% -$137K
CDZI icon
5652
Cadiz
CDZI
$322M
$41K ﹤0.01%
5,871
+4,319
+278% +$30.2K
FDEM icon
5653
Fidelity Emerging Markets Multifactor ETF
FDEM
$231M
$41K ﹤0.01%
1,575
+125
+9% +$3.25K
JQUA icon
5654
JPMorgan US Quality Factor ETF
JQUA
$7.27B
$41K ﹤0.01%
987
+201
+26% +$8.35K
KALV icon
5655
KalVista Pharmaceuticals
KALV
$708M
$41K ﹤0.01%
2,325
-575
-20% -$10.1K
LCTX icon
5656
Lineage Cell Therapeutics
LCTX
$306M
$41K ﹤0.01%
16,293
+7,205
+79% +$18.1K
LOAN
5657
Manhattan Bridge Capital
LOAN
$61.3M
$41K ﹤0.01%
6,000
+5,000
+500% +$34.2K
LYEL icon
5658
Lyell Immunopharma
LYEL
$246M
$41K ﹤0.01%
+141
New +$41K
MCRB icon
5659
Seres Therapeutics
MCRB
$139M
$41K ﹤0.01%
297
+59
+25% +$8.15K
PAI
5660
Western Asset Investment Grade Income Fund
PAI
$122M
$41K ﹤0.01%
2,630
SCJ icon
5661
iShares MSCI Japan Small-Cap ETF
SCJ
$149M
$41K ﹤0.01%
500
STOK icon
5662
Stoke Therapeutics
STOK
$1.29B
$41K ﹤0.01%
1,598
+291
+22% +$7.47K
HHLA.U
5663
DELISTED
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
$41K ﹤0.01%
4,100
-4,500
-52% -$45K
MSP
5664
DELISTED
Datto Holding Corp.
MSP
$41K ﹤0.01%
1,692
+382
+29% +$9.26K
CFFVU
5665
DELISTED
CF Acquisition Corp. V Unit
CFFVU
$41K ﹤0.01%
4,000
-6,017
-60% -$61.7K
ALDX icon
5666
Aldeyra Therapeutics
ALDX
$324M
$40K ﹤0.01%
4,560
+742
+19% +$6.51K
ARQQ icon
5667
Arqit Quantum
ARQQ
$513M
$40K ﹤0.01%
+80
New +$40K
BKKT icon
5668
Bakkt Holdings
BKKT
$152M
$40K ﹤0.01%
159
-35
-18% -$8.81K
CTKB icon
5669
Cytek Biosciences
CTKB
$501M
$40K ﹤0.01%
+1,843
New +$40K
DAO
5670
Youdao
DAO
$1.06B
$40K ﹤0.01%
3,342
+1,342
+67% +$16.1K
GERN icon
5671
Geron
GERN
$810M
$40K ﹤0.01%
29,073
+7,830
+37% +$10.8K
GREK icon
5672
Global X MSCI Greece ETF
GREK
$312M
$40K ﹤0.01%
1,476
-49
-3% -$1.33K
PLRX icon
5673
Pliant Therapeutics
PLRX
$97.6M
$40K ﹤0.01%
2,390
+743
+45% +$12.4K
PNI
5674
PIMCO New York Municipal Income Fund II
PNI
$77.2M
$40K ﹤0.01%
3,460
SPXL icon
5675
Direxion Daily S&P 500 Bull 3x Shares
SPXL
$5.81B
$40K ﹤0.01%
380